Drugs Made In America Acquisition Corp. Rights (NASDAQ:DMAAR) — Market Cap & Net Worth
Market Cap & Net Worth: Drugs Made In America Acquisition Corp. Rights (DMAAR)
Drugs Made In America Acquisition Corp. Rights (NASDAQ:DMAAR) has a market capitalization of $1.83 Million ($1.83 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30039 globally and #6038 in its home market, demonstrating a -0.99% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Drugs Made In America Acquisition Corp. Rights's stock price $0.10 by its total outstanding shares 20400000 (20.40 Million).
Drugs Made In America Acquisition Corp. Rights Market Cap History: 2025 to 2026
Drugs Made In America Acquisition Corp. Rights's market capitalization history from 2025 to 2026. Data shows growth from $3.82 Million to $2.04 Million (0.00% CAGR).
Drugs Made In America Acquisition Corp. Rights Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Drugs Made In America Acquisition Corp. Rights's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of DMAAR by Market Capitalization
Companies near Drugs Made In America Acquisition Corp. Rights in the global market cap rankings as of June 18, 2026.
Key companies related to Drugs Made In America Acquisition Corp. Rights by market ranking:
- Helios Underwriting PLC (LSE:HUW): Ranked #30030 globally with a market cap of $1.85 Million USD ( GBX15.24 Billion GBX).
- ALLIANCE ONE INT (F:DM8): Ranked #30031 globally with a market cap of $1.85 Million USD ( €1.59 Million EUR).
- Middlefield Canadian Income PCC - Middlefield Canadian Income - GBP PC (LSE:MCT): Ranked #30040 globally with a market cap of $1.83 Million USD ( GBX15.06 Billion GBX).
- Monarca Minerals Inc (V:MMN): Ranked #30041 globally with a market cap of $1.83 Million USD ( CA$2.53 Million CAD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #30030 | Helios Underwriting PLC | LSE:HUW | $1.85 Million | GBX213.00 |
| #30031 | ALLIANCE ONE INT | F:DM8 | $1.85 Million | €0.02 |
| #30040 | Middlefield Canadian Income PCC - Middlefield Canadian Income - GBP PC | LSE:MCT | $1.83 Million | GBX141.50 |
| #30041 | Monarca Minerals Inc | V:MMN | $1.83 Million | CA$0.02 |
Drugs Made In America Acquisition Corp. Rights Historical Marketcap From 2025 to 2026
Between 2025 and today, Drugs Made In America Acquisition Corp. Rights's market cap moved from $3.82 Million to $ 2.04 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.04 Million | -46.61% |
| 2025 | $3.82 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Drugs Made In America Acquisition Corp. Rights was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.83 Million USD |
| MoneyControl | $1.83 Million USD |
| MarketWatch | $1.83 Million USD |
| marketcap.company | $1.83 Million USD |
| Reuters | $1.83 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Drugs Made In America Acquisition Corp. Rights
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.